Related references
Note: Only part of the references are listed.Hemolytic Uremic Syndrome
Ellen M. Cody et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2019)
Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function
Federico Martinon-Torres et al.
PEDIATRICS (2018)
Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies
Jeremie Rosain et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood
Erika van der Maten et al.
SCIENTIFIC REPORTS (2017)
Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults
Monica Konar et al.
BLOOD (2017)
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
Sydel R. Parikh et al.
LANCET (2016)
Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion
Elise S. Hovingh et al.
FRONTIERS IN MICROBIOLOGY (2016)
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations
Fatimah Al-Ani et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2016)
Complement system part I - molecular mechanisms of activation and regulation
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
Compound heterozygous mutations in the C6 gene of a child with recurrent infections
Dineke Westra et al.
MOLECULAR IMMUNOLOGY (2014)
Combined Roles of Human IgG Subclass, Alternative Complement Pathway Activation, and Epitope Density in the Bactericidal Activity of Antibodies to Meningococcal Factor H Binding Protein
Serena Giuntini et al.
INFECTION AND IMMUNITY (2012)
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study
Maria Elena Santolaya et al.
LANCET (2012)
Complement deficiency states and associated infections
Lillemor Skattum et al.
MOLECULAR IMMUNOLOGY (2011)
Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus
Marzia M. Giuliani et al.
VACCINE (2010)
Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease
Dan M. Granoff
VACCINE (2009)
Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections
Tom Sprong et al.
BLOOD (2006)
Meningococcal surrogates of protection - serum bactericidal antibody activity
R Borrow et al.
VACCINE (2005)
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA
MA Seelen et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine
AE Platonov et al.
VACCINE (2003)
Share Paper
